Nasal polyposis: unusual indication for tracheostomy.

J Laryngol Otol

Department of Otolaryngology, Leighton Hospital, Crewe, UK.

Published: April 2004

AI Article Synopsis

  • A 70-year-old man with a decade-long history of nasal blockage sought medical attention due to stridor, leading to an urgent tracheostomy.
  • A large mass found in both nasal cavities prompted a biopsy, confirming the severity of his condition.
  • This case highlights the rarity of upper airway obstruction caused by nasal polyps, emphasizing the importance of timely intervention to avoid serious health issues.

Article Abstract

A rare case of nasal polyposis requiring urgent tracheostomy is reported. A 70-year-old male presented to the hospital with stridor. He had a 10-year history of nasal obstruction. A large proliferative mass was found to be occupying both the nasal cavities. An emergency tracheostomy and biopsy of the lesion was performed. A computerized axial scan (CT) demonstrated that the lesion occupied the pharynx reaching up to the laryngeal inlet. To our knowledge this is the first case reported in the literature. Upper airway obstruction from nasal polyps is uncommon but can cause significant morbidity if not appropriately managed.

Download full-text PDF

Source
http://dx.doi.org/10.1258/002221504323012085DOI Listing

Publication Analysis

Top Keywords

nasal polyposis
8
nasal
5
polyposis unusual
4
unusual indication
4
indication tracheostomy
4
tracheostomy rare
4
rare case
4
case nasal
4
polyposis requiring
4
requiring urgent
4

Similar Publications

Background: Nasal discharge is one of the cardinal symptoms of chronic rhinosinusitis, impacting over 50% of patients. For patients with symptoms refractory to standard medical therapy, endoscopic sinus surgery is an option. The objective of this study is to characterize how nasal discharge improves after surgery in patients with chronic rhinosinusitis.

View Article and Find Full Text PDF

Background: The treatment of refractory chronic rhinosinusitis with nasal polyps (CRSwNP) with omalizumab has been well studied based on clinical evaluation. Nevertheless, ideal quantitative or qualitative biomarkers for predicting a different response to biologics urgently need to be explored. We aim to identify potential biomarkers for predicting a good or poor response in patients with refractory CRSwNP.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!